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abdominal aortic aneurysm repair in a large tertiary
vascular center using a Medicare-derived risk
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Umair Qazi, MD, MPH, Bruce A. Perler, MD, Julie A. Freischlag, MD, and
Mahmoud B. Malas, MD, MHS, Baltimore, Md
Objective: Previous reports have documented better outcomes after open abdominal aortic aneurysm (AAA) repair in
tertiary centers compared with lower-volume hospitals, but outcome variability for endovascular AAA repair (EVAR) vs
open AAA repairs in a large tertiary center using a Medicare-derived mortality risk prediction model has not been pre-
viously reported. In the current study, we compared the observed vs predicted mortality after EVAR and open AAA repair
in a single large tertiary vascular center.
Methods: We retrospectively analyzed all patients who underwent repair of a nonruptured infrarenal AAA in our center
from 2003 to 2012. Univariable and multivariable logistic regression were used to evaluate 30-day mortality. Patients
were stratiﬁed into low-risk, medium-risk, and high-risk groups, and mortality was predicted for each patient based on
demographics and comorbidities according to the Medicare risk prediction model.
Results:We analyzed 297 patients (EVAR, 72%; open AAA repair, 28%; symptomatic, 25%). Most of our patients were of
high and moderate risk (48% and 28%, respectively). The observed 30-day mortality was 1.9% after EVAR vs 2.4% after
open repair (odds ratio [OR], 0.77; 95% conﬁdence interval [CI], 0.14-4.29; P [ .67). There was no difference in
mortality with EVAR vs open repair after adjusting for predeﬁned patient characteristics (OR, 0.92; 95% CI, 0.16-7.43;
P [ .93); only preoperative renal disease was predictive of 30-day mortality after AAA repair in our cohort (OR, 8.39;
95% CI, 1.41-67.0). The observed mortality within our study was signiﬁcantly lower than the Medicare-derived expected
mortality for each treatment group within patients stratiﬁed as high risk or medium risk (P # .0002 for all).
Conclusions: Despite treating patients with high preoperative risk status, we report a 10-fold decrease in operative
mortality for EVAR and open AAA repair in a tertiary vascular center compared with national Medicare-derived pre-
dictions. High-risk patients should be considered for aneurysm management in dedicated aortic centers, regardless of
approach. (J Vasc Surg 2015;61:291-7.)Abdominal aortic aneurysms (AAAs) affect between 4%
and 8% of people in the United States and account for
>7500 deaths annually.1,2 Historically, the surgical stan-
dard of care for symptomatic or large (>5.0 cm) AAAs
was open surgical repair. However, the advent of endovas-
cular aneurysm repair (EVAR) in recent years has drastically
changed current practice patterns, especially in the presence
of data suggesting that perioperative mortality is reduced
with EVAR.3-6 EVAR has also been demonstrated to reduce
perioperative complications and hospital length of stay
compared with open AAA repair, often making this the
favored approach among older and higher-risk patients.7-12the Division of Vascular and Endovascular Therapy, Johns Hopkins
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://dx.doi.org/10.1016/j.jvs.2014.04.078Despite this, long-term mortality after EVAR and open
AAA repair appears to be similar, and EVAR is associated
with higher costs, more intensive follow-up regimens,
and an increased need for reintervention postopera-
tively.6,9,11,13 As a result, the indications for performing
one approach over another are not currently clear. Several
algorithms to predict mortality have been developed in an
attempt to risk-stratify patients considering surgical repair
for AAA, including the Glasgow Aneurysm Score, Leiden
Score, Society for Vascular Surgery/American Association
for Vascular Surgery Comorbidity Scoring System, Hard-
man Index, Eagle Score, and Vascular Governance North-
West model.14-20 However, these models were developed
based on data only from patients undergoing open AAA
repair and have been shown to overpredict mortality in
the EVAR population.18,20 A more recent model proposed
by Giles et al15 used data from 45,660 Medicare beneﬁ-
ciaries to develop a scoring algorithm to predict periopera-
tive (30-day) mortality after EVAR or open AAA repair.
Patients are stratiﬁed as high risk, medium risk, and
low risk for surgical repair based on their age, sex, comor-
bidities, and proposed surgical approach, generating an
individualized risk assessment that can help guide clinical
decision making.291
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outcomes after EVAR vs open AAA repair in tertiary centers
speciﬁcally. Previous studies have demonstrated that early
mortality after AAA repair is highly dependent on hospital
volume and surgeon experience.21-23 This effect is thought
to be the result of better management of complications
such as renal failure at high-volume institutions24; the higher
mortality that is observed at lower-volume hospitals is
thought to be the result of a “failure to rescue” phenome-
non.25 The experience-based outcome variability for
EVAR has not yet been evaluated but would presumably
follow a similar pattern, with better outcomes observed in
more experienced, tertiary centers. In the current study, we
compare the perioperative morbidity and mortality observed
with EVAR vs open AAA repair at a single large tertiary
vascular center with the predicted mortality as generated
by application of the Giles risk stratiﬁcation model.
METHODS
Approval from the Johns Hopkins Hospital Institu-
tional Review Board was obtained before the study was
initiated. All patients who underwent elective infrarenal
AAA repair at our institution between November 28,
2003, and August 30, 2012, were identiﬁed for analysis.
The study excluded patients with connective tissue disor-
ders, inﬂammatory aneurysms, and ruptured aneurysms.
The electronic medical records were retrospectively
reviewed by two independent study team members to
collect data on patient demographics, symptoms, comor-
bidities, surgical technique, postoperative outcomes, and
mortality. Patient comorbidities were abstracted based on
physician documentation within the electronic medical re-
cord. Disagreements on patient coding were settled by
input from a third independent team member.
All patients with postoperative clinical visits <1 month
old were contacted by telephone to conﬁrm their mortality
status. Our primary outcome was perioperative mortality
(#30 days of surgery) after open AAA repair vs EVAR.
Our secondary outcome was the incidence of postoperative
acute renal failure (ARF), deﬁned according to Acute Kid-
ney Injury Network guidelines.26
Descriptive statistics are described as mean 6 standard
error of the mean or count with percentage, as appropriate.
Univariable statistics were performed using Student t-tests
for continuous variables or the Fisher or Pearson c2 tests,
or both, for categoric variables to compare morbidity and
mortality between patients undergoing open repair vs
EVAR. Multivariable logistic regression was used to eval-
uate adjusted observed perioperative mortality with open
repair vs EVAR after accounting for age, sex, and pertinent
patient comorbidities (congestive heart failure [CHF],
chronic obstructive pulmonary disease, coronary artery dis-
ease, and chronic renal insufﬁciency [CRI]) chosen based
on commonly included covariates from prior AAA risk
mortality prediction studies.15-19,27,28
Patients were then stratiﬁed into low-risk, medium-
risk, and high-risk groups using the risk prediction model
for perioperative mortality of EVAR vs open AAA repairdeveloped by Giles et al.15 In this model, each patient’s
risk of mortality after AAA repair is calculated using a logis-
tic regression equation that considers patient characteristics
(age, gender), comorbidities (end-stage renal disease
[ESRD], CRI, CHF, peripheral vascular disease, and cere-
brovascular disease), and treatment (open vs endovascular
approach) to derive an overall risk score: Risk score ¼ 4I
(female) þ 1I (age 70-75) þ 6I (age 76-80) þ 11I (age
>80) þ 9I (ESRD)þ 7I (CRI) þ 6I (CHF) þ 3I (vascular
disease) þ 12I (open surgery).
Note that in this equation, “I” is event, with I¼ 1 if the
event is true, 0 otherwise. Patient data were obtained from
manual record review and input into the Medicare-derived
equation to determine an individual overall mortality risk
score. Scores>11 were designated as high risk for mortality,
scores between 3 and 11 were designated as medium risk,
and scores<3 were designated as low risk. For risk stratiﬁca-
tion calculations performed within treatment groups, the
treatment effect coefﬁcient of 12 (open surgery) was
excluded, with respective mortality probabilities of <1%,
1% to 2%, and >2% for EVAR and <3%, 3% to 6%, and
>6% for open AAA repair, as reported by Giles et al.15
In addition, a speciﬁc Medicare-derived predicted mor-
tality probability (P) was calculated for each patient based on
the same model: logit(P) ¼ 5.02 þ 0.42  female þ
0.15  age(70 to 75) þ 0.63  age(76 to 80) þ 1.14 
age(>80) þ 0.71  CRI þ 0.95 ESRD þ 0.55 
CHF þ 0.30  vascular disease þ 1.17  open repair.
Observed vs expected mortality (calculated as observed
incidence of mortality/the expected incidence of mortality
as calculated based on the mean mortality probability within
a given group) was compared within risk groups to assess the
applicability of the model to predict mortality within our in-
stitution’s patient population. Note that within the mortal-
ity prediction equation, risk with open AAA repair is
weighted 1.17 times more than EVAR. Because we noted
a particularly high predicted mortality within our patient
cohort, we also performed sensitivity analyses with and
without the weighted treatment coefﬁcient for open AAA
repair (1.17) to determine whether including it signiﬁcantly
affected the calculated predicted mortality risk.
RESULTS
Observed experience. Overall, 297 patients (79.4%
male), with a mean age of 72.86 0.47 years, were identiﬁed
for inclusion in the study. Of these, 214 (72.1%) underwent
EVAR and 83 (27.9%) underwent open AAA repair. Pa-
tients undergoing open repair were younger (69.2 6 0.86
vs 74.3 6 0.54 years; P < .0001) and had a higher preva-
lence of smoking (71.1% vs 54.7%; P ¼ .01) compared
with patients undergoing EVAR. There were no signiﬁcant
differences in patient gender, race, comorbidities, or symp-
tomatology between groups (Table I).
Death #30 days of surgery occurred in 2.02% (n ¼ 6)
of patients overall. The observed perioperative mortality
was 1.9% (n ¼ 4) after EVAR vs 2.4% (n ¼ 2) after open
repair (odds ratio [OR], 0.77; 95% conﬁdence interval
[CI], 0.14-4.29; P ¼ .67). There was no difference in
Table I. Patient characteristics by repair type
Characteristica
Open AAA repair
(n ¼ 83)
EVAR
(n ¼ 214) P value
Sex .345
Male 63 (75.9) 173 (80.8)
Female 20 (24.1) 41 (19.2)
Age, years 69.2 6 0.86 74.3 6 0.54 <.0001
Symptomatic 25 (30.1) 50 (23.4) .229
Diabetes 12 (14.5) 38 (17.8) .495
Hypertension 75 (90.4) 180 (84.1) .165
Dyslipidemia 63 (75.9) 166 (77.6) .759
CHF 4 (4.8) 24 (11.2) .091
COPD 25 (30.1) 55 (25.7) .441
CAD 47 (56.6) 106 (49.5) .272
Vascular disease 11 (13.3) 39 (18.2) .304
CRI 19 (22.9) 45 (21.0) .726
ESRD 3 (3.6) 5 (2.3) .542
Cancer 18 (21.7) 54 (25.2) .522
Smoking 59 (71.1) 117 (54.7) .01
AAA, Abdominal aortic aneurysm; CAD, coronary artery disease; CHF,
congestive heart failure; COPD, chronic obstructive pulmonary disease;
CRI, chronic renal insufﬁciency; ESRD, end stage renal disease; EVAR,
endovascular AAA repair.
aAge is expressed as mean 6 standard error of the mean, and categoric
variables are shown as number (%).
Table II. Multivariable analysis of mortality after
abdominal aortic aneurysm (AAA) repair
Covariate OR (95% CI) P value
Age 1.03 (0.92-1.15) .60
Male gender 0.93 (0.05-7.11) .95
CHF 0.82 (0.04-7.71) .88
COPD 2.78 (0.48-16.3) .24
CAD 0.84 (0.13-5.11) .85
CRI 8.39 (1.41-67.0) .02
EVAR vs open AAA repair 0.92 (0.16-7.43) .93
CAD, Coronary artery disease; CHF, congestive heart failure; CI, conﬁ-
dence interval; COPD, chronic obstructive pulmonary disease; CRI, chronic
renal insufﬁciency; OR, odds ratio.
Fig 1. Risk stratiﬁcation of patients undergoing abdominal aortic
aneurysm (AAA) repair. Most patients in our study were catego-
rized as moderate risk or high risk for AAA repair surgery ac-
cording to the mortality risk scoring equation developed by Giles
et al.15 EVAR, Endovascular aneurysm repair.
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predeﬁned patient characteristics (OR, 0.92; 95% CI,
0.16-7.43; P ¼ .93). Only preoperative renal disease was
predictive of 30-day mortality after AAA repair in our
cohort (OR, 8.39; 95% CI, 1.41-67.0; Table II).
Postoperative ARF occurred in 2.4% (n ¼ 6) of patients
overall. ARF was more common after open repair (6.0%
[n ¼ 5]) compared with EVAR (0.5% [n ¼ 1]; OR, 14.3;
95% CI, 1.64-125; P ¼ .006). However, no patients who
developed ARF died secondary to this complication.
Observed vs expected experience. Most patients in
our study were categorized as moderate-risk (27.6% [n ¼
82]) or high-risk (48.1% [n ¼ 143]) for AAA repair ac-
cording to the mortality risk scoring equation developed by
Giles et al15 (Fig 1). The expected mean operative mor-
tality within our study cohort was 20.9% (95% CI, 17.1%-
24.9%) overall, including 23.4% (95% CI, 15.5%-31.3%)
after open repair and 20.1% (95% CI, 15.6%-24.6%) afterEVAR. Among low-risk open AAA repair patients, the
observed vs expected mortality of 3.01% vs 2.1% was similar
(P ¼ .77). However, the observed mortality was signiﬁ-
cantly lower than the expected mortality for medium-risk
and high-risk open AAA and all EVAR patients regardless
of risk stratiﬁcation (P # .0002 for all; Fig 2; Table III).
To address the possibility that our predicted mortality
might be exaggerated, we performed sensitivity analyses
with and without the weighted treatment coefﬁcient for
open AAA repair. Results of this analysis demonstrated
that the predicted mortality risk for open AAA and
EVAR were unchanged, regardless of whether the treat-
ment coefﬁcient was included (P ¼ NS):
Expected mortality for open repair:
d With treatment effect: 23.4%
d Without treatment effect: 17.7%
Expected mortality for EVAR:
d With treatment effect: 20.1%
d Without treatment effect: 20.1%DISCUSSION
Previous reports have documented better outcomes af-
ter open AAA repair in tertiary centers compared with
lower-volume hospitals,29 but outcome variability for
EVAR vs open AAA repairs in a large tertiary center using
a Medicare-derived mortality risk prediction model has not
been previously reported. In the current study, we
compared the observed vs predicted mortality after
EVAR and open AAA repair in a single large tertiary
vascular center. We found that our 30-day mortality rates
are much lower than expected with both operative ap-
proaches, particularly in patients who were stratiﬁed as
medium-risk and high-risk. ARF was more common after
open repair but did not affect mortality outcomes.
AAA repair is a high-risk operation, with 30-day mor-
tality rates estimated to range between 2% and 5%, depend-
ing on the operative approach.30-33 As a result, predictive
Fig 2. Observed vs expected mortality. A, The observed mortality was signiﬁcantly lower than the expected mortality
for each treatment group overall. When stratiﬁed by operative risk, low-risk open abdominal aortic aneurysm (AAA)
patients had similar observed and predicted mortality rates, whereas medium-risk and high-risk (B) open AAA and all
(C) endovascular aneurysm repair (EVAR) patients had signiﬁcantly lower rates.
Table III. Observed vs expected mortality rates after abdominal aortic aneurysm (AAA) repair
Treatment group No.
30-day mortality
P valueObserved, % (95% CI) Expected, % (95% CI)
Overall 297 2.0 (0.4-3.6) 20.9 (17.1-24.9) <.0001
Open AAA repair 83 2.4 (0.96 to 5.8) 23.4 (15.5-31.3) <.0001
Low-risk 33 3.0 (3.1 to 9.2) 2.1 (2.1-2.2) .77
Medium-risk 40 0 23.3 (12.7-33.8) <.0001
High-risk 10 0.1 (12.6 to 32.6) 93.8 (90.0-97.6) <.0001
EVAR 214 1.9 (0.04-3.6) 20.1 (15.6-24.6) <.0001
Low-risk 72 0.0 0.7 (0.7-0.7) <.0001
Medium-risk 84 2.4 (0.9 to 5.7) 10.6 (6.0-15.1) .0002
High-risk 58 3.4 (1.4 to 8.3) 57.9 (47.7-68.0) <.0001
CI, Conﬁdence interval; EVAR, endovascular AAA repair.
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ular for clinical decision making. The idea is that patients
will be able to go into surgery being fully informed of their
surgical risk with EVAR or open AAA repair, thus enabling
them to make a truly informed decision about whether
they are willing to accept the higher risks of an open repair
vs potential longer-term complications and the need for
lifelong surveillance after EVAR.6 In an effort to facilitate
this individualization of care, a number of risk prediction
models for AAA have been developed.14-20,27,34 Most of
these models include patient age and comorbidities (specif-
ically, preoperative renal and cardiac disease) to generate a
predicted risk of mortality after surgery (Table IV).
In our study, the observed vs predicted mortality rates
with EVAR and open AAA repair were drastically different.Of note, the 20.9% predicted mortality of our patient
cohort is markedly higher than the standardly reported
mortality rates after AAA repair that tend to range between
1% and 5%.15,35 This likely reﬂects that many patients are
referred to our tertiary institution after being deemed too
high-risk for surgery at other centers. Although open repair
is generally reserved for younger, healthier patients, many
patients who undergo open repair at our institution do so
because they have unsuitable anatomy for EVAR even
though they have a high clinical risk with open repair.
Consistent with this notion, 50 of 83 patients (60%) under-
going open AAA repair were classiﬁed as medium-risk or
high-risk in our study.
In addition, we failed to demonstrate the short-term
mortality beneﬁt with EVAR compared with open AAA
Table IV. Existing abdominal aortic aneurysm (AAA) mortality risk prediction algorithms
Risk prediction model Scoring algorithm
Glasgow Aneurysm
Score19
Risk score ¼ age in years þ (7 for myocardial disease) þ (10 for cerebrovascular disease) þ
(14 for renal disease)
Leiden Risk Model18 Risk score ¼ (4 if age <60; þ0 if age ¼ 70; þ4 if age >80) þ (4 for female gender) þ (3 for history
of MI) þ (8 for CHF) þ (8 for electrocardiographic evidence of ischemia) þ (12 for renal disease) þ
(7 for pulmonary disease)
SVS/AAVS Comorbidity
Scoring System16
Grades (absent ¼ 0; mild ¼ 1; moderate ¼ 2; severe ¼ 3) given for cardiac, pulmonary, renal, and
hypertensive disease as well as for age (0 if age <55; 1 if age 55-69; 2 if age 70-79; 3 if age >80).
Risk score ¼ (age) þ (4  cardiac) þ (2  pulmonary) þ (2  renal) þ (hypertension)
Hardman Index17 Risk score ¼ (þ1 if age >76) þ (1 if creatinine >176) þ (1 if hemoglobin <9) þ (1 if
electrocardiographic evidence of ischemia) þ (1 if loss-of-consciousness on arrival)
Eagle Score27 Risk score ¼ 0.077  (age e 10) þ (1 if history of angina) þ (1.4 if Q wave on electrocardiogram) þ
(1.2 if history of ventricular ectopic activity) þ (1 if history of diabetes) þ (1.3 if ischemic
electrocardiographic changes) þ (2.3 if redistribution of thallium)
Giles Medicare Score15 Risk score ¼ (þ1 if age 70-75; þ6 if age 76-80; þ11 if age >80) þ (4 if female) þ (9 if ESRD) þ
(7 if CRI þ (6 if CHF) þ (3 if vascular disease) þ (12 if open repair)
VGNW Model28 Odds ¼ exp (9.3431 þ [0.0486  age (continuous in years)] þ [0.7322  female sex] þ [0.6620 
diabetes] þ [0.0073  creatinine (continuous in mmol/L)] þ [0.4718  respiratory disease] þ
[0.7762  antiplatelet medication] þ [1.3130  open surgery]). Risk ¼ [odds/(1 þ odds)]  100
AAVS, American Association for Vascular Surgery; CHF, congestive heart failure; CRI, chronic renal insufﬁciency; ESRD, end-stage renal disease; MI,
myocardial infarction; SVS, Society for Vascular Surgery; VGNW, Vascular Governance NorthWest.
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ences in our data compared with previously published
data are also most likely a reﬂection of institutional practice
patterns, whereby many high-risk patients regularly un-
dergo extensive surgical interventions.
Among centers that routinely treat patients who
would likely not be offered surgery at smaller institutions,
multidisciplinary approaches to patient care and a strict
adherence to hospital quality guidelines are common.36-38
For example, the 6% rate of postoperative ARF after
open AAA repair in our study was similar to that previ-
ously reported in the literature14 and signiﬁcantly higher
than the ARF rate after EVAR. However, all patients
undergoing AAA repair at our institution are monitored
by a multidisciplinary intensive care team that includes
physicians from a variety of training backgrounds, as
well as intensivists, pharmacists, physical and occupa-
tional therapists, and nutritionists. As a result, the gener-
ally recognized postoperative risks for patient mortality
after AAA repair may be minimized by early recognition
and involvement of expert clinicians to help optimize
each patient’s individual postoperative course.
A large study byGhaferi et al,24 found that hospital mor-
tality after inpatient surgery was dependent on the early
recognition and management of major postoperative com-
plications rather than an actual reduction in complication
rates. More recently, Waits et al39 demonstrated that a large
proportion of the variation reported after AAA repair is
driven by “failure to rescue” or death by a major postop-
erative complication. These ﬁndings support the concept
that hospital-level factors and safety culture likely play a
large role in postoperative outcomes within speciﬁc patient
populations and may partially explain why tertiary institu-
tions such as our own routinely report better outcomes af-
ter AAA repair than are reported in national databases.The problem with using existing AAA repair risk predic-
tion models is that no adjustment is made for surgeon-
speciﬁc or institution-speciﬁc factors that may affect
patient outcomes after surgery. Previous studies have
demonstrated signiﬁcant hospital-level effects on out-
comes after surgery in many specialties.22,40-43 With
respect to AAA repairs speciﬁcally, a large meta-analysis
of >100,000 surgeries performed in the United Kingdom
between 2001 and 2005 demonstrated an odds of death of
0.67 for procedures performed in high-volume ($32
cases/y) vs low-volume centers.23 On the basis of this
data, the authors estimate that performing AAA repairs
at low-volume centers results in 15 extra deaths per
1000 cases. Similar ﬁndings have been reported for
EVAR repairs as well,22 and surgeon experience has also
been shown to play a role.21,44,45
Despite these data, no current risk predictionmodels ac-
count for surgeon-level or hospital-level effects. One reason
for this is likely that most models were developed from
single-institution experiences. Although Giles et al15 devel-
oped their model from a broader selection of patients (ie,
Medicare beneﬁciaries), institutional effects were not
considered in the analysis. Choke et al46 recently demon-
strated that an “in-house” risk model for elective AAA repair
is more accurate in predicting perioperative mortality than
existing single-institution or national models, presumably
because themodel is speciﬁc for local demographics, case se-
lection, and practice patterns. The dichotomous observed vs
predicted outcomes that we report are likely reﬂective of the
differences in our patient population compared with the
standard Medicare beneﬁciary from which the Giles score
was derived. Similar to how the American College of Sur-
geons National Surgical Quality Improvement Program
database reports outcomes using risk-adjusted and case-
mix-adjusted modeling,47 a risk adjustment that accounts
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necessary to truly evaluate a patient’s risk with AAA surgery.
The ﬁndings that we report are limited by a number of
factors, including the retrospective design of our study,
relatively small sample size, and lack of long-term outcome
data. As with any retrospective record review, there is a risk
of inaccurate data reporting. We attempted to minimize
this possibility by having two independent researchers
collect patient data individually and confer with a third in-
dependent party at any point when there was a disagree-
ment. A larger sample size may reduce the differences
that we report in our observed vs expect mortality. How-
ever, although only 83 patients were in the open AAA repair
group, a power calculation based on our sample size
(EVAR, 214; open AAA repair, 83) with a ¼ .05 demon-
strated that our study had 99.9% power to detect a differ-
ence in mortality between groups, and it is unlikely that
the 10-fold difference in outcomes that we report would
have equalized even with a signiﬁcantly larger cohort.
This is one of the ﬁrst studies that we know of to
apply the Medicare-based prediction modeling for
AAA repair to a cohort of patients treated at a tertiary
vascular center. With the increasing movement for
AAA surgery to be performed at centers of excellence,
delineating postoperative outcomes in high-risk patients
treated at experienced institutions is essential.29 Minimal
data are available comparing perioperative mortality
with EVAR vs open AAA surgery at high-volume vs
low-volume institutions. It will be interesting to note
whether future long-term studies at practiced vascular
centers replicate the long-term differences in outcomes
with the different operative approaches that have been
previously reported.6
CONCLUSIONS
Despite treating patients with high preoperative risk
status, we report a 10-fold decrease in operative mortality
for EVAR and also open AAA repair in a tertiary vascular
center compared with national Medicare-derived predic-
tions. High-risk patients should be considered for aneu-
rysm management in dedicated aortic centers, regardless
of approach. Future studies are needed to determine to
true extent of surgeon-level and hospital-level effects on
operative morbidity and mortality after AAA repair.
We acknowledge Mimmie Kwong, MD, for her assis-
tance in collecting data related to this project.
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